🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05699629
Recruiting Observational

Prospective Coronary Heart Disease Cohort

NCT05699629 · tracked via the Priya Life Science China tracker
Sponsor
Shandong First Medical University
Phase
Observational
Started
2022-01-21
Last updated
2023-02-13

Condition(s) studied

Coronary Heart DiseaseMyocardial Infarction

Study summary

To evaluate the biomarkers for the prognosis of coronary heart disease, patients with coronary heart disease will be recruited and followed up for at least 2 years.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Diagnosed as coronary heart disease or with unexplained chest pain needed to undergo coronary angiography. * Healthy subjects undergoing routine physical examination in the physical examination department and willing to sign informed consent will be recruited as control subjects. Exclusion Criteria: * With malignant tumors, infectious diseases and advanced liver diseases. * Won't sign an inform consent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Shandong First Medical University Jinan Shandong Recruiting

More Shandong First Medical University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05699629 on ClinicalTrials.gov ↗ ← All trials in China